Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease

Brainomix and Boehringer Ingelheim launched a strategic partnership to evaluate the real-world impact of Brainomix's e-Lung imaging software to improve the identification and access to treatment for people with progressive pulmonary fibrosis (PPF) in the US. This marked the start of an ongoing collaboration in fibrosing lung disease.